<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Drugs that inhibit specific <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase (HDAC) activities have enormous potential in preventing the consequences of <z:hpo ids='HP_0011009'>acute</z:hpo> injury to the <z:mp ids='MP_0008912'>nervous</z:mp> system and in allaying <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, very little is known about the expression pattern of the HDACs in the central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Identifying the cell types that express HDACs in the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> is important for determining therapeutic targets for HDAC inhibitors and evaluating potential side effects </plain></SENT>
<SENT sid="3" pm="."><plain>We characterized the cellular expression of HDACs 1-3, and HDACs 4 and 6, in the adult mouse brain in the cingulate cortex, parietal cortex, dentate gyrus, and CA1 regions of the hippocampus and subcortical white matter </plain></SENT>
<SENT sid="4" pm="."><plain>Expression of class I HDACs showed a cell-and region-specific pattern </plain></SENT>
<SENT sid="5" pm="."><plain>Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, or global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by in vitro oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, altered the extent of HDAC expression in a region- and cell-specific manner </plain></SENT>
<SENT sid="6" pm="."><plain>The pan-HDAC inhibitor, SAHA, reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced alterations in HDACs </plain></SENT>
<SENT sid="7" pm="."><plain>The results suggest that in addition to promoting epigenetic changes in transcriptional activity in the nucleus of neurons and glia, HDACs may also have non-transcriptional actions in axons and the distant processes of glial cells and may significantly modulate the response to injury in a cell- and region-specific manner </plain></SENT>
</text></document>